UniSa - IRIS Institutional Research Information System

PAPACCIO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 493
EU - Europa 122
AS - Asia 97
OC - Oceania 2
SA - Sud America 2
Totale 716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 492
SG - Singapore 75
IT - Italia 53
IE - Irlanda 27
DE - Germania 14
CN - Cina 12
GB - Regno Unito 5
ES - Italia 4
IN - India 4
UA - Ucraina 4
FI - Finlandia 3
FR - Francia 3
HU - Ungheria 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
Totale 716
Salva come PNG Salva come JPEG
Città #
Chandler 128
Princeton 95
Singapore 55
Ashburn 36
Dublin 27
Andover 24
Redwood City 23
Dallas 18
Wilmington 18
Ann Arbor 15
Naples 12
Seattle 8
Springfield 4
Washington 4
Aprilia 3
Beijing 3
Duncan 3
Edinburgh 3
Houston 3
Milan 3
Munich 3
Norwalk 3
Paris 3
Rome 3
Assago 2
Budapest 2
Castellammare di Stabia 2
Hangzhou 2
Islington 2
Jacksonville 2
Lappeenranta 2
Madrid 2
New Delhi 2
Poggiomarino 2
Pune 2
Tokyo 2
Amsterdam 1
Belvedere Spinello 1
Boardman 1
Bogotá 1
Boston 1
Brighton 1
Brussels 1
Böblingen 1
Caserta 1
Chicago 1
Dambulla 1
Esslingen am Neckar 1
Fairfield 1
Forest City 1
Fort Worth 1
Guangzhou 1
Gunzenhausen 1
Helsinki 1
Istanbul 1
Kuala Lumpur 1
Montreal 1
Mountain View 1
Mugnano di Napoli 1
Prineville 1
Pullach im Isartal 1
Quito 1
Reston 1
Salalah 1
San Jose 1
Stockholm 1
Sydney 1
Tallinn 1
Vienna 1
Warsaw 1
Weifang 1
West Jordan 1
Wuxi 1
Totale 558
Salva come PNG Salva come JPEG
Nome #
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 47
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 42
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 33
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 32
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 31
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 29
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 29
In the literature: August 2018 29
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 29
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 29
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 29
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 28
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 28
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 26
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 26
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 25
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 25
Implication of the Hedgehog pathway in hepatocellular carcinoma 24
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 24
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 23
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 23
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 17
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 16
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 16
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 15
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 14
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 13
Will Organoids Fill the Gap towards Functional Precision Medicine? 12
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 12
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 11
Circulating cancer stem cells: an interesting niche to explore 10
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 8
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 8
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 6
Stemness markers of osteosarcoma 5
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 5
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 5
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 5
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 5
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 5
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 4
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 4
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 4
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 4
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 4
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 3
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 3
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 3
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 3
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 3
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 3
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 3
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 3
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 3
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 3
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 3
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 3
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 2
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 2
Patient-derived organoids as a tool for modelling localized colorectal cancer 2
Totale 861
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 25 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/202569 8 24 37 0 0 0 0 0 0 0 0 0
Totale 861